Option Care Health (OPCH) Tops Q4 EPS by 3c, Offers FY Guidance

Option Care Health (NASDAQ: OPCH) reported Q4 EPS of $0.10, $0.03 better than the analyst estimate of $0.07. Revenue for the quarter came in at $804.7 million versus the consensus estimate of $793 million.

GUIDANCE:

Option Care Health sees FY2021 revenue of $3.2-3.25 billion, versus the consensus of $3.22 billion.

• Net revenue of $3.20 billion to $3.25 billion
• Adjusted EBITDA of $245.0 million to $258.0 million
• Cash flow from operations of at least $140.0 million
• Net debt to Adjusted EBITDA leverage ratio at December 31, 2021 below 4.0x

For earnings history and earnings-related data on Option Care Health (OPCH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M